151 related articles for article (PubMed ID: 2271376)
1. The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.
Coleman MD; Scott AK; Breckenridge AM; Park BK
Br J Clin Pharmacol; 1990 Nov; 30(5):761-7. PubMed ID: 2271376
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the rat during chronic dapsone administration.
Coleman MD; Tingle MD; Park BK
J Pharm Pharmacol; 1991 Mar; 43(3):186-90. PubMed ID: 1675276
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the presence of trimethoprim in the rat.
Coleman MD; Russell RM; Tingle MD; Park BK
J Pharm Pharmacol; 1992 Feb; 44(2):114-8. PubMed ID: 1352810
[TBL] [Abstract][Full Text] [Related]
4. The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.
Coleman MD; Rhodes LE; Scott AK; Verbov JL; Friedmann PS; Breckenridge AM; Park BK
Br J Clin Pharmacol; 1992 Sep; 34(3):244-9. PubMed ID: 1389948
[TBL] [Abstract][Full Text] [Related]
5. The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes.
Tingle MD; Coleman MD; Park BK
Br J Clin Pharmacol; 1991 Jul; 32(1):120-3. PubMed ID: 1888631
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of dapsone-induced methaemoglobinaemia in the rat isolated perfused liver.
Coleman MD; Hoaksey PE; Breckenridge AM; Park BK
J Pharm Pharmacol; 1990 May; 42(5):302-7. PubMed ID: 1976775
[TBL] [Abstract][Full Text] [Related]
7. Dapsone toxicity: some current perspectives.
Coleman MD
Gen Pharmacol; 1995 Nov; 26(7):1461-7. PubMed ID: 8690232
[TBL] [Abstract][Full Text] [Related]
8. An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system.
Tingle MD; Coleman MD; Park BK
Br J Clin Pharmacol; 1990 Dec; 30(6):829-38. PubMed ID: 2288829
[TBL] [Abstract][Full Text] [Related]
9. Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy.
Rhodes LE; Tingle MD; Park BK; Chu P; Verbov JL; Friedmann PS
Br J Dermatol; 1995 Feb; 132(2):257-62. PubMed ID: 7888363
[TBL] [Abstract][Full Text] [Related]
10. A dapsone-induced blood dyscrasia in the mouse: evidence for the role of an active metabolite.
Ahmadi M; Khalaf LF; Smith HJ; Nicholls PJ
J Pharm Pharmacol; 1996 Feb; 48(2):228-32. PubMed ID: 8935178
[TBL] [Abstract][Full Text] [Related]
11. Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance.
Coleman MD
Br J Dermatol; 1993 Nov; 129(5):507-13. PubMed ID: 8251346
[TBL] [Abstract][Full Text] [Related]
12. Gonadal influence on the metabolism and haematological toxicity of dapsone in the rat.
Coleman MD; Tingle MD; Winn MJ; Park BK
J Pharm Pharmacol; 1990 Oct; 42(10):698-703. PubMed ID: 1982141
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo dapsone release from hydroxyapatite reservoirs.
Lasserre A; Berty S; Bajpai PK
Biomed Sci Instrum; 1997; 33():149-54. PubMed ID: 9731351
[TBL] [Abstract][Full Text] [Related]
14. The disposition of dapsone in cirrhosis.
May DG; Arns PA; Richards WO; Porter J; Ryder D; Fleming CM; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1992 Jun; 51(6):689-700. PubMed ID: 1611807
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo.
Mitra AK; Thummel KE; Kalhorn TF; Kharasch ED; Unadkat JD; Slattery JT
Clin Pharmacol Ther; 1995 Nov; 58(5):556-66. PubMed ID: 7586950
[TBL] [Abstract][Full Text] [Related]
16. The effects of cimetidine on the oxidative metabolism of estradiol.
Galbraith RA; Michnovicz JJ
N Engl J Med; 1989 Aug; 321(5):269-74. PubMed ID: 2747769
[TBL] [Abstract][Full Text] [Related]
17. The contribution of N-hydroxylation and acetylation to dapsone pharmacokinetics in normal subjects.
May DG; Porter JA; Uetrecht JP; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1990 Dec; 48(6):619-27. PubMed ID: 2249373
[TBL] [Abstract][Full Text] [Related]
18. Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors.
Bluhm RE; Adedoyin A; McCarver DG; Branch RA
Clin Pharmacol Ther; 1999 Jun; 65(6):598-605. PubMed ID: 10391665
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of dapsone-induced methaemoglobinaemia in the rat.
Coleman MD; Winn MJ; Breckenridge AM; Park BK
Biochem Pharmacol; 1990 Feb; 39(4):802-5. PubMed ID: 2306285
[No Abstract] [Full Text] [Related]
20. Effects of H(2)-receptor antagonists on dapsone-induced methaemoglobinaemia in rats.
Malfará WR; Pereira CP; Santos AC; Queiroz RH
Pharmacol Res; 2002 Apr; 45(4):269-73. PubMed ID: 12030789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
